PDF factsheet
      Z

embolic protection in atrial fibrillation for all type of patients, clinical trials results

Watchman versus warfarin
PROTECT-AF,
NCT00129545
closure of the left atrial appendage(LAA) using the Watchman device
versus
long-term warfarin therapy
patients with documented nonvalvular atrial fibrillation who could take long-term warfarin, but without any indication that would require warfarinopen
Follow-up duration: 900 patients-year
US, Europe

  Options


in first

in second

  Filter